TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

January 31, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

etanercept given by perispinal administration

Trial Locations (1)

90095

100 UCLA Medical Plaza, Suites 205-210, Los Angeles

All Listed Sponsors
lead

Tobinick, Edward Lewis, M.D.

OTHER

NCT00203320 - TNF-Alpha Inhibition for Treatment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter